Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
MIRN98 microRNA-98, rat
Known as:
miR-98, rat
, microRNA-98, rat
, rno-mir-98
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
MicroRNAs
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MiRNA-98-5p inhibits the progression of osteosarcoma by regulating cell cycle via targeting CDC25A expression.
X. Liu
,
M. Cui
European Review for Medical and Pharmacological…
2019
Corpus ID: 208623368
OBJECTIVE The aim of this study was to elucidate the exact role of microRNA-98-5p (miRNA-98-5p) in the progression of…
Expand
2018
2018
[miR-98-5p promotes apoptosis and inhibits migration by reducing the level of STAT3 in A549 cells].
Huilin Liu
,
Min Wei
,
Guoxia Wang
Xi bao yu fen zi mian yi xue za zhi = Chinese…
2018
Corpus ID: 52310283
Objective To explore the effects of microRNA-98-5p (miR-98-5p) on the growth of lung cancer A549 cells and its mechanism. Methods…
Expand
2017
2017
The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.
Zichuang Yan
,
Yongjing Liu
,
+5 authors
Yan Xu
Molecular Biosystems
2017
Corpus ID: 25210612
Copy number alteration (CNA) represents an important class of genetic variations that may contribute to tumorigenesis, tumor…
Expand
2016
2016
miR-98-5p Acts as a Target for Alzheimer’s Disease by Regulating Aβ Production Through Modulating SNX6 Expression
Qiushi Li
,
Xidong Li
,
L. xilinx Wang
,
Yanhui Zhang
,
Long Chen
Journal of Molecular Neuroscience
2016
Corpus ID: 255482719
Accumulation of amyloid β-peptide (Aβ) in the brain of Alzheimer disease (AD) patients is believed to be the main pathological…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE